A1 versus A2
Milk of European breeds is addictive, triggers schizophrenia,diabetes and cardiovascular diseases
In July 2007, Dr Keith Woodford, a professor of farmmanagement at New Zealand’s Lincoln Universitypublished a paper titled A2 Milk, Farmer Decisions, and Risk Management that reported how “approximately 500 New Zealand dairy farmers are converting their herds to eliminate production of A1 beta-casein within the milk” responsible for “Type 1 diabetes, heart disease and autism”.
Dr Woodford went on to explain: “The alternative (to A1) is A2 beta-casein, and the associated milk is known as A2 milk. Originally all cow milk was of the A2 type. However, a genetic mutation, probably between 5000 and 10,000 years ago, has resulted in a proportion ofcows of European breeds producing a casein variant called A1 beta-casein. A1 beta-casein is absent in the milk of pure Asian and African cattle.”
He offered “eight strands to the evidence” to the ill-effects of A1 beta-casein: countries with high intakes of A1 beta-casein are the countries with high levels of Type 1 diabetes and heart disease; A1 and A2 beta-caseindigest differently and only A1 beta-casein releases beta-casomorphin7 (BCM7) which is a powerful opioid(addictive) and causes arterial plaque; rabbits fed A1 beta-casein develop considerably more plaque on their aorta and rats show higher incidence of Type 1 diabetes;evidence from American and European investigationsshow that autistic and schizophrenic persons typically excrete large quantities of BCM7 in their urine; and many who are intolerant to milk are able to drink A2 milk.
Dr Woodford was worried that most consumers and dairy farmers worldwide remained unaware of the issues surrounding A1 and A2 milk. Within four years, Indian scientists at the National Bureau of Animal Genetic Resources (NBAGR) came up with their own study. “The A2 allele gene in Indian milk breeds of cows and buffalos are 100 per cent, while in foreign breeds, it is around 60 per cent,” it said in 2011.
NBAGR screened the status of the A2 allele of the beta-casein gene in 22 indigenous breeds and the twodominant foreign breeds Holstein Friesian and Jersey. While the A2 allele was 100 per cent in the top five indigenous milch breeds –Red Sindhi, Sahiwal,Tharparkar, Gir and Rathi – and around 94 per cent in other indigenous dual and draught breeds, its status was merely 60 per cent in Holstein Friesian and Jersey.
According to Dr Woodford, the major consumer market for A2 milk is in Australia where it is available in some 800 supermarkets and 200 convenience stores.However, overall market share is probably less than 1% because of limited publicity. In an increasingly health conscious world, this creates a huge potential for global demand for the A2 milk of our indigenous breeds. For now, we must rethink our strategy of flooding the domestic markets with A1 milk by aggressively pushing exotic breeds at home and opening up the dairy sector toforeign brands.
Milk of European breeds is addictive, triggers schizophrenia,diabetes and cardiovascular diseases
In July 2007, Dr Keith Woodford, a professor of farmmanagement at New Zealand’s Lincoln Universitypublished a paper titled A2 Milk, Farmer Decisions, and Risk Management that reported how “approximately 500 New Zealand dairy farmers are converting their herds to eliminate production of A1 beta-casein within the milk” responsible for “Type 1 diabetes, heart disease and autism”.
Dr Woodford went on to explain: “The alternative (to A1) is A2 beta-casein, and the associated milk is known as A2 milk. Originally all cow milk was of the A2 type. However, a genetic mutation, probably between 5000 and 10,000 years ago, has resulted in a proportion ofcows of European breeds producing a casein variant called A1 beta-casein. A1 beta-casein is absent in the milk of pure Asian and African cattle.”
He offered “eight strands to the evidence” to the ill-effects of A1 beta-casein: countries with high intakes of A1 beta-casein are the countries with high levels of Type 1 diabetes and heart disease; A1 and A2 beta-caseindigest differently and only A1 beta-casein releases beta-casomorphin7 (BCM7) which is a powerful opioid(addictive) and causes arterial plaque; rabbits fed A1 beta-casein develop considerably more plaque on their aorta and rats show higher incidence of Type 1 diabetes;evidence from American and European investigationsshow that autistic and schizophrenic persons typically excrete large quantities of BCM7 in their urine; and many who are intolerant to milk are able to drink A2 milk.
Dr Woodford was worried that most consumers and dairy farmers worldwide remained unaware of the issues surrounding A1 and A2 milk. Within four years, Indian scientists at the National Bureau of Animal Genetic Resources (NBAGR) came up with their own study. “The A2 allele gene in Indian milk breeds of cows and buffalos are 100 per cent, while in foreign breeds, it is around 60 per cent,” it said in 2011.
NBAGR screened the status of the A2 allele of the beta-casein gene in 22 indigenous breeds and the twodominant foreign breeds Holstein Friesian and Jersey. While the A2 allele was 100 per cent in the top five indigenous milch breeds –Red Sindhi, Sahiwal,Tharparkar, Gir and Rathi – and around 94 per cent in other indigenous dual and draught breeds, its status was merely 60 per cent in Holstein Friesian and Jersey.
According to Dr Woodford, the major consumer market for A2 milk is in Australia where it is available in some 800 supermarkets and 200 convenience stores.However, overall market share is probably less than 1% because of limited publicity. In an increasingly health conscious world, this creates a huge potential for global demand for the A2 milk of our indigenous breeds. For now, we must rethink our strategy of flooding the domestic markets with A1 milk by aggressively pushing exotic breeds at home and opening up the dairy sector toforeign brands.
Very nice article I love it, desi cow milk provide you good health. Calcium found in desi cow milk protects the colon cells from chemicals which lead to cancer.
ReplyDelete